RNXtract® for MammaTyper®
Quick, simple and efficient extraction of nucleic acid from FFPE samples
- Complementary CE IVD-marked product for the MammaTyper kit
- Faster procedure eliminates the need for a column system in nucleic acid purification by utilizing magnetic beads.
- Environmentally friendly and safer for users as it does not utilize a deparaffinization reagent and reduces plastic material waste.
RNXtract® Nucleic Acid Extraction Kit
RNXtract® is intended for routine clinical use for extraction and purification of total nucleic acid from formalin-fixed and paraffin-embedded (FFPE) sample material.
The kit includes eight reagent vials supporting 48 extractions and is validated for use with the MammaTyper® assay.
Graphical Representation of the Procedure
RNXtract® Nucleic Acid Extraction Kit overview:
- Purifies nucleic acids from FFPE samples
- Magnetic bead–based binding ensures efficient nucleic acid isolation with high purity and yield.
- Optimized washing removes proteins, nucleases, and impurities for high purity
- No deparaffinization step is required making the process user-safe and environmentally friendly.
- No plastic columns used → reduces nucleic acid loss during purification
Supporting literature:
Varga Z, Lebeau A, Bu H, Hartmann A, Penault-Llorca F, Guerini-Rocco E, Schraml P, Symmans F, Stoehr R, Teng X, Turzynski A, von Wasielewski R, Gürtler C, Laible M, Schlombs K, Joensuu H, Keller T, Sinn P, Sahin U, Bartlett J, Viale G. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®. Breast Cancer Res. 2017 May 11;19(1):55. doi: 10.1186/s13058-017-0848-z. PMID: 28490348; PMCID: PMC5426065.
Laible M, Schlombs K, Kaiser K, Veltrup E, Herlein S, Lakis S, Stöhr R, Eidt S, Hartmann A, Wirtz RM, Sahin U. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer. 2016 Jul 7;16:398. doi: 10.1186/s12885-016-2476-x. PMID: 27389414; PMCID: PMC4936300.
Gürtler C, Laible M, Schwabe W, Steinhäuser H, Li X, Liu S, Schlombs K, Sahin U. Transferring a Quantitative Molecular Diagnostic Test to Multiple Real-Time Quantitative PCR Platforms. J Mol Diagn. 2018 Jul;20(4):398-414. doi: 10.1016/j.jmoldx.2018.02.004. Epub 2018 Apr 3. PMID: 29625248.
| Feature | RNXtract® Nucleic Acid Extraction Kit |
| Sample type | 10 uM FFPE tissue section (tumor cell content >20 %) |
| Sample capacity | 48 extractions |
| Product Classification | IVDD |
| Technology | Binding of nucleic acids to magnetic beads |
| Elution Volume | 100 µL |
| Extraction Time | Approximately 2.5 hours |
| Final Product | Total Nucleic Acid |
| Pre-deparaffinization of FFPE | Not required |
| Storage Conditions | Stable at room temperature for up to 12 months |
| Catalogue Number | CC01011 |
References
- Wirtz RM et al., Breast Cancer Res Treat 2016; 157(3), 437446
- Varga Z et al., Breast Cancer Res 2017; 19(55), 1-13
- Caselli E et al., PLOS ONE 2021; 16(9), 1-18
- Shaaban A et al., Eur J Cancer 2022; 175(1), 87-88
Sysmex Europe SE
Deelböge 19 D
22297 Hamburg
Germany
+49 (40) 527 26 0
+49 (40) 527 26 100

